Skip to main content
Premium Trial:

Request an Annual Quote

Bruker s Organic Q4 Revenues Dip Slightly Though Loss Turns to Profit

NEW YORK, Feb. 23 (GenomeWeb News) - Bruker BioSciences yesterday reported fourth quarter 2005 revenues of $80.6 million, down from $85.6 million in the fourth quarter of 2004.

 

Revenues increased by 1 percent when adjusted for foreign currency effects, the company said.

 

Bruker reported net income of $1.9 million for the period ended Dec. 31, compared to a loss of $900,000 in the year-ago period.

 

R&D expenses dropped to $9.4 million in the current quarter, versus $12.1 million in the similar quarter last year.

 

The company had around $99.7 million in cash and short-term investments as of Dec. 31.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.